Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who live in Scotland, are aged 60 or older, and have been diagnosed with advanced AMD (age-related macular degeneration).
- People who have been receiving treatment at Princess Alexandra Eye Pavilion (PAEP) for at least 6 months and whose condition has been responding positively to that treatment.
- People who are able to give their informed consent (formal agreement) to take part in the study before it begins.
Who may not be able to join:
- People who are not able to speak and read English, as interpreters are not yet included at this stage of the study (the trial site notes this may change in a future phase).
- People who have recently had invasive eye surgery, such as cataract removal, at their most recent eye appointment.
- People who are unwilling or unable to provide informed consent to participate.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Peter Cackett, Princess Alexandra Eye Pavilion
Phone: +447442374789
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Visual frailty
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.